You have 9 free searches left this month | for more free features.

radioembolization

Showing 1 - 25 of 158

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Transarterial Radioembolization in COlorectal MEtastasis of

Not yet recruiting
  • Transarterial Radioembolization
  • Therasphere
  • (no location specified)
Sep 7, 2023

Hypoxia Before Radioembolization Treatment With 18F-FMISO PET

Recruiting
  • Radioembolization
  • +3 more
  • 18F-Fluoromisonidazole PET
  • Ankara, Turkey
    Ankara University
Sep 7, 2023

Hepatocellular Carcinoma (HCC) Trial (Durvalumab, Bevacizumab, Transarterial Radioembolization (TARE))

Not yet recruiting
  • Hepatocellular Carcinoma (HCC)
  • (no location specified)
Sep 11, 2023

Liver Metastases, Breast Cancer Trial in Leuven, Amsterdam (Quiremspheres™)

Recruiting
  • Liver Metastases
  • Breast Cancer
  • Quiremspheres™
  • Leuven, Vlaams-Brabant, Belgium
  • +1 more
Nov 16, 2023

Carcinoma, Hepatocellular Trial (Therasphere 90Y, Microwave Ablation)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • Therasphere 90Y
  • Microwave Ablation
  • (no location specified)
Jul 12, 2023

Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer Trial (EYE90 Microspheres Treatment)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • EYE90 Microspheres Treatment
  • (no location specified)
Jul 12, 2023

Hepatocellular Carcinoma Trial in Brussels (Radioembolization using Holmium-166)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Radioembolization using Holmium-166
  • Brussels, Anderlecht, Belgium
    Hôpital Universitaire Erasme, ULB
Dec 7, 2022

Hepatocellular Carcinoma Non-resectable Trial (Holmium-166 radioembolization)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Holmium-166 radioembolization
  • Utrecht, Netherlands
    UMC Utrecht
Nov 7, 2022

Primary Liver Cancer, Non-Resectable Hepatocellular Carcinoma Trial (MRI-guided radioembolization)

Not yet recruiting
  • Primary Liver Cancer
  • Non-Resectable Hepatocellular Carcinoma
  • MRI-guided radioembolization
  • (no location specified)
Nov 1, 2022

Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Boston (Durvalumab, Tremelimumab,

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 18, 2023

Thrombocytopenia, Cirrhosis Trial in Chicago (TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.)

Recruiting
  • Thrombocytopenia
  • Cirrhosis
  • TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.
  • Chicago, Illinois
    Northwestern University/Northwestern Memorial Hospital
Sep 7, 2022

Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

Not yet recruiting
  • Locally Advanced Intrahepatic Cholangiocarcinoma
  • +4 more
  • Angiography
  • +8 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Sep 22, 2023

HepatoCellular Carcinoma Trial in Singapore (Y-90 Radioembolization, Nivolumab)

Active, not recruiting
  • HepatoCellular Carcinoma
  • Singapore, Singapore
    National Cancer Centre - Singapore
May 25, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Carcinoma in the Liver Trial in Atlanta

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Y-90 SIR-Spheres
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 7, 2022

Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer Trial in Houston (procedure, radiation, other)

Active, not recruiting
  • Metastatic Liver Carcinoma
  • +3 more
  • Angiography
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Hepatocellular Carcinoma Trial (Holmium-166 treatment, Holmium-166 work-up)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Holmium-166 treatment
  • Holmium-166 work-up
  • (no location specified)
Jul 6, 2022

Biopsy After Radioembolization to Identify Changes in Tumor

Recruiting
  • Colon Cancer Liver Metastasis
  • +5 more
  • Y90 TARE
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 30, 2022

Colon Cancer, Rectal Cancer, Liver Metastases Trial in San Francisco (Tas-102, SIR-Sphere)

Completed
  • Colon Cancer
  • +2 more
  • San Francisco, California
    University of California San Francisco
Jul 28, 2022

Hepatocellular Carcinoma, Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma Trial in Dallas (Atezolizumab and

Not yet recruiting
  • Hepatocellular Carcinoma
  • Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
  • Atezolizumab and bevacizumab
  • transarterial chemoembolization (TACE) or transarterial radioembolization (TARE
  • Dallas, Texas
    Simmons Comprehensive Cancer Center at University of Texas South
Sep 9, 2022

Liver Cancer, Hepatocellular Carcinoma, Metastatic Colorectal Cancer Trial in Boston (Standard microcatheter, PEDD device)

Recruiting
  • Liver Cancer
  • +2 more
  • Standard microcatheter
  • PEDD device
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
May 17, 2022

Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Neuroendocrine Neoplasm
  • Arterial Embolization
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Dec 22, 2022

Colorectal Cancer Metastatic, Colon Cancer, Metastatic Colorectal Cancer Trial in Iowa City (Durvalumab, Yttrium-90

Recruiting
  • Colorectal Cancer Metastatic
  • +9 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Mar 24, 2022

Colorectal Cancer Metastatic Trial (radioembolization, Standard of care first-line systemic therapy)

Not yet recruiting
  • Colorectal Cancer Metastatic
  • radioembolization
  • Standard of care first-line systemic therapy
  • (no location specified)
Oct 26, 2021

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Metastatic Extrahepatic Bile Duct Cancer Trial in

Active, not recruiting
  • Adult Primary Hepatocellular Carcinoma
  • +6 more
  • PET scan
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 21, 2022

Hepatocellular Carcinoma Trial in Philadelphia (Yttrium-90 Microsphere Radioembolization, Perflutren Protein-Type A

Recruiting
  • Hepatocellular Carcinoma
  • Yttrium-90 Microsphere Radioembolization
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Nov 2, 2021